Home / Publications / On the Pulse / A focus on compulsory licensing for pharmaceutical...

CMS On the Pulse episode #9: A focus on compulsory licensing for pharmaceutical companies

Nick Beckett talks with Jonathan Chu (CMS Hong Kong), Sheena Jacob (CMS Singapore) and Thomas Hirse (CMS Germany).

In this episode, we discuss:

  • the rationale for compulsory licences and the requirements for granting the same
  • the rights of patent owners faced with the threat of compulsory licences
  • any requirement for patent owners to also provide know-how and technical support under a compulsory licence
  • limitations on exploitation under compulsory licences, including labelling requirements and distribution channel restrictions
  • the use of compulsory licences to deal with the supply of medical necessities during COVID-19
  • the debate regarding the need for COVID-19 vaccine patent waivers

Watch the video

Episode #9 - Compulsory licensing

Listen to the podcast

Authors

Show more Show less
Thomas Hirse
Dr. Thomas Hirse
Partner
Rechtsanwalt
Duesseldorf
Nick Beckett
Nick Beckett
Managing Partner
Managing Partner, Beijing and Hong Kong Offices, Head of Asia-Pacific IP and Life Sciences & Healthcare
Beijing
Jonathan Chu
Jonathan Chu
Partner
Hong Kong (CMS CMNO - Lau, Horton & Wise LLP)
Sheena Jacob
Sheena Jacob
Partner
Singapore
Previous 10 / 10 Next